Dexmedetomidine Alleviates Postoperative Delirium After Brain Tumor Resections

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

January 28, 2022

Conditions
DexmedetomidinePostoperative Delirium
Interventions
DRUG

Dexmedetomidine

Ten minutes after anesthesia induction and endotracheal intubation, patients assigned to dexmedetomidine group were given a loading dose of dexmedetomidine 0.6 μg/kg over 10 minutes, followed by continuous infusion at a rate of 0.4 μg/kg/h until the start of dural closure.

DRUG

0.9% saline

0.9% saline is administered with the same volume at the same speed as the other group.

Trial Locations (2)

100070

Beijing TianTan Hospital,Capital Medical University, Beijing

100853

PLA General Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT04674241 - Dexmedetomidine Alleviates Postoperative Delirium After Brain Tumor Resections | Biotech Hunter | Biotech Hunter